0001209191-13-050999.txt : 20131106
0001209191-13-050999.hdr.sgml : 20131106
20131106162539
ACCESSION NUMBER: 0001209191-13-050999
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20131104
FILED AS OF DATE: 20131106
DATE AS OF CHANGE: 20131106
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: VERTEX PHARMACEUTICALS INC / MA
CENTRAL INDEX KEY: 0000875320
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 043039129
STATE OF INCORPORATION: MA
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 130 WAVERLY STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139-4242
BUSINESS PHONE: 6173416100
MAIL ADDRESS:
STREET 1: 130 WAVERLY STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139-4242
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Silva Paul M
CENTRAL INDEX KEY: 0001446372
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-19319
FILM NUMBER: 131196782
MAIL ADDRESS:
STREET 1: C/O VERTEX PHARMACEUTICALS INCORPORATED
STREET 2: 130 WAVERLY ST
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2013-11-04
0
0000875320
VERTEX PHARMACEUTICALS INC / MA
VRTX
0001446372
Silva Paul M
C/O VERTEX PHARMACEUTICALS INCORPORATED
130 WAVERLY ST.
CAMBRIDGE
MA
02139
0
1
0
0
SVP & Corp Controller
Common Stock
2013-11-04
4
M
0
937
39.05
A
12687
D
Common Stock
2013-11-04
4
M
0
937
38.80
A
13624
D
Common Stock
2013-11-04
4
M
0
1125
37.86
A
14749
D
Common Stock
2013-11-04
4
S
0
1858
66.64
D
12891
D
Common Stock
2013-11-04
4
S
0
1141
67.22
D
11750
D
Common Stock
169
I
401(k)
Stock Option (right to buy)
39.05
2013-11-04
4
M
0
937
0.00
D
2020-02-03
Common Stock
937
938
D
Stock Option (right to buy)
38.80
2013-11-04
4
M
0
937
0.00
D
2021-02-02
Common Stock
937
4688
D
Stock Option (right to buy)
37.86
2013-11-04
4
M
0
1125
0.00
D
2022-02-01
Common Stock
1125
10125
D
Transaction made pursuant to Mr. Silva's company approved trading plan under Rule 10b5-1.
Open market sales reported on this line occurred at a weighted average price of $66.64 (range $66.30 to $66.99).
Mr. Silva undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.
Open market sales reported on this line occurred at a weighted average price of $67.22 (range $67.00 to $67.38).
The option vests in 16 quarterly installments from 2/4/2010.
The option vests in 16 quarterly installments from 2/3/2011.
The option vests in 16 quarterly installments from 2/2/2012.
Kenneth L. Horton, Attorney-In-Fact
2013-11-06